Inovio Pharmaceuticals shares were down 20% to $2.99 after hours as the company said it plans to sell stock and accompanying warrants.

Inovio Pharmaceuticals Inc. closed $10.99 below its 52-week high ($14.75), which the company reached on April 1st.

(Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inovio Pharmaceuticals (INO – Research Report), ...

USA News Group News Commentary ? Artificial intelligence (AI) is revolutionizing healthcare, offering solutions that could dramatically reduce deficits in the U.S. healthcare system. The U.S. Food and ...

Inovio (INO) announced data from a retrospective trial showing that the number of Recurrent Respiratory Papillomatosis , or RRP, patients ...

INOVIO (NASDAQ: INO) has announced a stock option grant to a newly hired employee under its 2022 Inducement Plan. The award ...

Inovalis Real Estate Investment Trust (the “REIT”) (TSX: INO.UN) today announced the signing of an exchange contract for the sale of the Sablière prop ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential. We've set up an alert service to help ...